Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Ryanodine receptor 2–mediated calcium leak is associated with increased glyoxalase I in the aging brain
Elizabeth Woo, … , Amy F.T. Arnsten, Lauren H. Sansing
Elizabeth Woo, … , Amy F.T. Arnsten, Lauren H. Sansing
Published October 16, 2025
Citation Information: JCI Insight. 2025;10(22):e184041. https://doi.org/10.1172/jci.insight.184041.
View: Text | PDF
Research Article Aging Neuroscience

Ryanodine receptor 2–mediated calcium leak is associated with increased glyoxalase I in the aging brain

  • Text
  • PDF
Abstract

Alzheimer disease (AD) is characterized by plaques and tangles, including calcium dysregulation and glycated products produced by reactive carbonyl compounds. AD brains have increased glyoxalase I (GLO1), a major scavenger of inflammatory carbonyl compounds, at early, but not later, stages of disease. Calcium dysregulation includes calcium leak from phosphorylated ryanodine receptor 2 (pS2808-RyR2), seen in aged macaques and AD mouse models, but the downstream consequences of calcium leak remain unclear. Here, we show that chronic calcium leak is associated with increased GLO1 expression and activity. In macaques, we found age-related increases in GLO1 expression in the prefrontal cortex (PFC), correlating with pS2808-RyR2, and localized to dendrites and astrocytes. To examine the relationship between GLO1 and RyR2, we used S2808D-RyR2 mutant mice exhibiting chronic calcium leak through RyR2, and found increased GLO1 expression and activity in the PFC and hippocampus as early as 1 month and as late as 21 months of age, with a bell-shaped aging curve. These aged S2808D-RyR2 mice demonstrated impaired working memory. As with macaques, GLO1 was expressed in astrocytes and neurons. Proteomics data generated from S2808D-RyR2 synaptosomes confirmed GLO1 upregulation. Altogether, these data suggest potential association between GLO1 and chronic calcium leak, providing resilience in early stages of aging.

Authors

Elizabeth Woo, Dibyadeep Datta, Shveta Bathla, Hannah Beatty, Pinar Caglayan, Ashley Kristant Albizu, TuKiet T. Lam, Jean Kanyo, Mary Kate Joyce, Shannon Leslie, Stacy Uchendu, Jonathan DeLong, Qinyue Stacy Guan, Jiaxin Li, Efrat Abramson, Alison L. Herman, Dawson Cooper, Pawel Licznerski, Tamas L. Horvath, Elizabeth A. Jonas, Angus C. Nairn, Amy F.T. Arnsten, Lauren H. Sansing

×

Figure 6

GLO1 expression and activity are increased in the frontal cortex and hippocampus in young and adult S2808D-RyR2 mice.

Options: View larger image (or click on image) Download as PowerPoint
GLO1 expression and activity are increased in the frontal cortex and hip...
(A) Immunoblot images of GLO1 expression in synaptosomes from 3-month-old and 12-month-old male S2808D-RyR2 frontal cortex. (B) Quantification of GLO1 expression normalized to total protein content based on stain-free blot (mean ± SEM). n = 5–7 per group per age. (C) Immunoblot images of GLO1 expression in synaptosomes from 3-month-old and 12-month-old S2808D-RyR2 hippocampus. (D) Quantification of GLO1 expression normalized to total protein content using stain-free blot (mean ± SEM). n = 5–7 per group per age. (E) Quantification of GLO1 activity levels (mean ± SEM). n = 5–7 per group per age. S2808D, S2808D-RyR2. *P < 0.05, **P < 0.01, ***P < 0.001 by Mann-Whitney U test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts